Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry
Bone Marrow Transplantation, Published online: 07 October 2023; doi:10.1038/s41409-023-02118-wComparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry
Source: Bone Marrow Transplantation - Category: Hematology Authors: Risa Koresawa-Shimizu Ritsuro Suzuki Yasufumi Uehara Nobuhiro Hiramoto Masashi Sawa Takahiro Fukuda Keisuke Kataoka Yoshinobu Kanda Tatsuo Oyake Yasushi Kubota Naoyuki Uchida Shingo Yano Hikaru Kobayashi Junji Tanaka Yoshiko Atsuta Eisei Kondo Source Type: research
More News: Bone Marrow Transplant | Chemotherapy | Hematology | Japan Health | Lymphoma | Stem Cell Therapy | Stem Cells | Transplants